Make Medicine Affordable Act

12/29/2022, 11:03 PM

Summary of Bill HR 7497

Bill 117 hr 7497, also known as the Make Medicine Affordable Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the rising costs of prescription medications in the United States and make them more affordable for all Americans.

One of the key provisions of the Make Medicine Affordable Act is the establishment of a Prescription Drug Affordability Board. This board would be responsible for setting limits on the prices of prescription drugs, based on factors such as the cost of production and the prices of similar medications in other countries. The board would also have the authority to negotiate prices with drug manufacturers to ensure that medications are priced fairly and affordably.

Additionally, the bill includes measures to increase transparency in the pharmaceutical industry. Drug manufacturers would be required to disclose information about the costs of production, research and development, and marketing for each medication. This transparency is intended to help consumers understand why certain medications are priced the way they are and hold manufacturers accountable for pricing practices. Furthermore, the Make Medicine Affordable Act includes provisions to expand access to generic medications and promote competition in the pharmaceutical market. This would help drive down prices and make medications more affordable for consumers. The bill also includes measures to improve the availability of affordable prescription drugs for low-income individuals and seniors. Overall, the Make Medicine Affordable Act aims to address the issue of skyrocketing prescription drug prices in the United States and make medications more accessible and affordable for all Americans. It remains to be seen how this legislation will be received in Congress and whether it will ultimately be passed into law.

Congressional Summary of HR 7497

Make Medicine Affordable Act

This bill establishes several programs and requirements to address the prices of prescription drugs, including (1) requiring the Centers for Medicare & Medicaid Services to negotiate the prices of certain brand-name drugs and insulin under Medicare, (2) capping annual out-of-pocket spending under the Medicare prescription drug benefit, and (3) limiting cost-sharing for insulin products.

Current Status of Bill HR 7497

Bill HR 7497 is currently in the status of Bill Introduced since April 11, 2022. Bill HR 7497 was introduced during Congress 117 and was introduced to the House on April 11, 2022.  Bill HR 7497's most recent activity was Referred to the Subcommittee on Health. as of April 12, 2022

Bipartisan Support of Bill HR 7497

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7497

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 7497

Make Medicine Affordable ActMake Medicine Affordable ActTo provide for lower prices for drugs through drug price negotiation, and for other purposes.
Start holding our government accountable!

Comments

Sponsors and Cosponsors of HR 7497

Latest Bills

A bill to amend the Small Business Act to eliminate certain requirements relating to the award of construction subcontracts within the county or State of performance.
Bill S 991March 31, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Waste Emissions Charge for Petroleum and Natural Gas Systems: Procedures for Facilitating Compliance, Including Netting and Exemptions".
Bill HJRES 35March 29, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of Energy Efficiency and Renewable Energy, Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Commercial Refrigerators, Freezers, and Refrigerator-Freezers".
Bill HJRES 75March 29, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Energy relating to "Energy Conservation Program: Energy Conservation Standards for Walk-In Coolers and Walk-In Freezers".
Bill HJRES 24March 29, 2025
No 340B Savings for Transgender Care Act
Bill HR 2197March 29, 2025
Major Richard Star Act
Bill HR 2102March 29, 2025
Ending China’s Unfair Advantage Act of 2025
Bill HR 2115March 29, 2025
IMPACT Act 2.0
Bill HR 2122March 29, 2025
Protecting Individuals with Down Syndrome Act
Bill HR 2251March 29, 2025
To amend title 14, United States Code, to require the retention of certain enlisted members of the Coast Guard who have completed 18 or more, but less than 20, years of service, and for other purposes.
Bill HR 2200March 29, 2025
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Bill HR 6833September 5, 2023
Inflation Reduction Act of 2022
Bill HR 5376September 5, 2023
BIOSIM Act
Bill HR 2815March 8, 2023